Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine
adverse drug reaction
agitation
agitation, childhood, acute
akineton
alpha methyldopa hydrazine
amantadine
aminoglycoside
amitriptyline
amphetamines
ampicillin
anesthesia, general
anterocollis
antiarrhythmic drugs
antibiotics
antibiotics, neurologic complications with
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinergic poisoning
anticholinesterase
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
antiemetic
antihistamines
artane
atropine
atropine psychosis
autonomic dysfunction
belladonna
beta adrenergic blocker
bradykinesia
brain damage
calcium antagonist
carbidopa
catatonia
catatonia, lethal
children
chloroquine
chlorpromazine
chorea
ciprofloxacin
clozapine
cogentin
coma
complications
confusion
confusional state, acute
constipation
contrast agents, neurotoxicity of
cooling therapy
creatine phosphokinase(CPK)elevated
cyproheptidine
dehydration
delirium
dementia
deprenyl
dilantin
dopamine
dopamine agonist
dopamine antagonist
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug overdose
drug withdrawal
dyskinesia
dystonia
dystonia, cervical
dystonia, drug induced
dystonia, face
dystonia, focal
dystonia, treatment of
dystonia, truncal
dystonic reaction, acute
emergencies, medical
emergencies, neurologic
enzyme inhibition
erythromycin
exercise
fever
fluoroquinolones
grasping
hallucination
hallucination, visual
haloperidol
heatstroke
herbs
hyperthermia
iatrogenic neurologic disorders
imipramine
interferon
L-dopa
L-dopa, controlled release
L-dopa, drug interactions with and side effects of
L-dopa, potentiators of
leukocytosis
levonorgestrel
lithium
livedo reticularis
liver function enzymes
malignant hyperpyrexia
memory, defect of recent
memory, impairment of
mental status, abnormal
methacholine
migraine
migraine, prophylaxis
misdiagnosis
monoamine oxidase inhibitors
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, extrapyramidal-treatment of
movement disorder, treatment of
myasthenia gravis
myasthenia gravis, drug induced
myasthenia gravis, unmasked
myasthenic syndrome
myoglobinuria
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neuromuscular blockade
nicotine
obesity
old age, neurology of
orthostatic hypotension
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, drug induced
Parkinson disease, fluctuations in
Parkinson disease, misdiagnosis
Parkinson disease, on-off phenomena in
Parkinson disease, treatment of
parsidol
patient information and support
penicillamine
personality change
phenothiazine
physostigmine
Pisa syndrome
poison, neurologic problems with
prevention of neurologic disorders
procyclidine
prognosis
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychosis, acute
pupil, abnormality in neurologic disorders
pupil, dilated, bilateral
pyridoxine
quinidine
renal failure
reserpine and reserpine like drugs
retrocollis
review article
rhabdomyolysis
rigidity
risk factors
ritalin
schizophrenia
seizure
serotonin syndrome
sinemet
skin, dry
steroid
tachycardia
tardive dystonia
tea
timolol
toxins, nervous system
tranquilizers, neurologic complications with
treatment of neurologic disorder
tremor
tricyclic antidepressant
verapamil
vertigo
vertigo, treatment of
vision, blurred
vitamin, multiple
xerostomia
Showing articles 500 to 550 of 7681 << Previous Next >>

Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices
NEJM 377:2555-2564, Nazarian, S.,et al, 2017

Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial
Lancet 390:2481-2489, Green, A.J.,et al, 2017

Oral Anticoagulants for Prevention of Stroke in Atrial Fibrillation: Systematic Review, Network Meta-Analysis, and Cost Effectiveness Analysis
BMJ 359:J5058, Lopez-Lopez, J.A.,et al, 2017

CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017

Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients with Medication-Refractory, Tremor-Dominant Parkinson Disease
JAMA Neurol 74:1412-1418, Bond, A.E.,et al, 2017

Pacemakers in MRI for the Neuroradiologist
AJNR 38:2222-2230, Korutz, A.W.,et al, 2017

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017

Zolpidem for the Treatment of Neurologic Disorders
JAMA Neurol 74:1130-1139, Bomalaski, M.N.,et al, 2017

Recrudescence of Deficits After Stroke
JAMA Neurol 74:1048-1055, Topcuoglu, M.A.,et al, 2017

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017

Five Cases of Malignant Melanoma During Fingolimod Treatment in Dutch Patients with MS
Neurol 89:970-972, Killestein, J.,et al, 2017

Computed Tomographic Perfusion to Predict Response to Recanalization in Ischemic Stroke
Ann Neurol 81:849-856, Lansberg, M.G.,et al, 2017

Chess Study Revives Debate Over Cognition-Enhancing Drugs
JAMA doi:10.1001/JAMA:2017.8114, Lyon, J., 2017

DAWN: Thrombectomy Effective Up to 24 Hours after Stroke
Medscape May, Hughes, S., 2017

Intrathecal 2-hydroxypropyl-�-cyclodextrin Decreases Neurological Disease Progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial
Lancet 390:1758-1768, Ory, D.S.,et al, 2017

Safety of Pregnancy after Cerebral Venous Thrombosis
Stroke 48:3130-3133, Aguiar de Sousa, D.,et al, 2017

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
NEJM 377:1713-1722,1786, Mendell, J.R.,et al, 2017

Effects of Spaceflight on Astronaut Brain Structure as Indicated on MRI
NEJM 377:1746-1753, Roberts, D.R.,et al, 2017

Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017

Infliximab for the Treatment of CNS Sarcoidosis
Neurol 89:2092-2100, Gelfand, J.M.,et al, 2017

Clinical Imaging Factors Associated with Infarct Progression in Patients with Ischemic Stroke During Transfer for Mechanical Thrombectomy
JAMA Neurol 74:1361-1367,1298, Boulouis, G.,et al, 2017

Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017

Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting
Stroke 48:2769-2775, Weimar, C.,et al, 2017

Treatment and Outcome of Hemorrhagic Transformation after Intravenous Alteplase in Acute Ischemic Stroke
Stroke 48:e343-e361, Yaghi, S.,et al, 2017

Low-Dose Aspirin and Risk of Intracranial Bleeds
Neurol 89:2280-2287, Soriano, L.C.,et al, 2017

Idiopathic Hyperammonemia after Solid Organ Transplantation: Primarily a Lung Problem? A Single-Center Experience and Systematic Review
ClinTransplant 31:e12957, Krutsinger, D.,et al, 2017

A Case of Statin-Associated Autoimmune Myopathy
Clin Med Insights: Case Reports 10:1-4, Sweidan, A.J.,et al, 2017

Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations
RadioGraphics 37:562-576, Starkey, J.,et al, 2017

Candida Infections of the Central Nervous System
UptoDate Jan, Kauffman, C.A., 2016

Subarachnoid Hemorrhage
Medscape Aug, Becske, T. & Lutsep, H.L., 2016

Mechanisms, Causes, and Effects of Hypercapnia
UptoDate Dec, Feller-Kopman, D.J. & Schwartzstein, R.M., 2016

Long-Term Treatment of Epilepsy with Everolimus in Tuberous Sclerosis
Neurol 87:2408-2415, Krueger, D.A.,et al, 2016

Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016

Safety and Outcome of Intra-Arterial Treatment for Basilar Artery Occlusion
JAMA Neurol 73:1225-1230, Van Houwelingen, R.C.,et al, 2016

Clinical Relevance of Microbleeds in Acute Stroke Thrombolysis
Neurol 87:1534-1541, Charidimou, A.,et al, 2016

A Benign But Potentially Life-Threatening Headache
Neurol 87:e168-e173, Zhang, D.,et al, 2016

Short Time Interval Between Neurologic Event and Carotid Surgery is Not Associated with an Increased Procedural Risk
Stroke 47:2783-2790, Tsantilas, P.,et al, 2016

Stroke Risk and Mortality in Patients with Ventricular Assist Devices
Stroke 47:2702-2706,2677, Parikh, N.S.,et al, 2016

Early Start of DOAC after Ischemic Stroke
Neurol 87:1856-1862,1652, Seiffge, D.J.,et al, 2016

Clinicopathologic Conference, Aqueductal Stenosis with Hydrocephalus
NEJM 375:2583-2593, Case 40-2016, 2016

Neonatal Abstinence Syndrome
NEJM 375:2468-2479, McQueen, K. & Murphy-Oikonen, J., 2016

Use of MRI in the Diagnosis of Fetal Brain Abnormalities in Utero (MERIDIAN): A Multicentre, Prospective Cohort Study
, Griffiths, P.D.,et al, 2016

Favorable Bridging Therapy Based on DWI-FLAIR Mismatch in Patients with Unclear-Onset Stroke
AJNR 37:88-93, Mourand, I.,et al, 2016

Tranexamic Acid-Associated Seizures: Causes and Treatment
Ann Neurol 79:18-26, Lecker, I.,et al, 2016

Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic STroke
Stroke 47:581-641, Demaerschalk, B.M.,et al, 2016

Natalizumab-Related PML 2 Weeks after Negative Anti-JCV Antibody Assay
Neurol 86:484-486, Gagne, M.S.,et al, 2016

Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants
JAMA Neurol 73:169-177,155, Purrucker, J.C.,et al, 2016

A 62-Year-Old Woman with Bizarre Behavior and Recurrent Episodes of Behavioral Arrest
Neurol 86:e62-e65, Briglia, H.,et al, 2016

Statin-Associated Autoimmune Myopathy
NEJM 374:664-669, Mammen, A.L., 2016

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
NEJM 374: DOI:10.1056/NEJMoa1506930, Kernan, W.N.,et al, 2016



Showing articles 500 to 550 of 7681 << Previous Next >>